Amgen will invest $200 million in its new technology centre in Hyderabad, India, this year, with plans for further investments. The centre,...

Amgen leases 500,000 sq ft in Hyderabad to establish its first global capability centre, enhancing its office space in the city. The new ce...

The delegation held Roundtable Conferences on business, AI and semiconductors, spanning coast to coast, and also met with CEOs, founders an...

US biotech giant Amgen announced plans to open a new technology and innovation site in Hyderabad, India. The site will be located in HITEC ...

A notable book that emphasized the importance of corporate culture by looking at successful companies (stock price performance as a guide) ...

Allam, who served as the CEO at the Public Investment Fund prior to joining Cadila Pharmaceuticals, will report to Group Chairman and Manag...

Syngene is a fully integrated CRAMS company and Biocon has around 70% stake in it. Syngene also has a wholly-owned subsidiary in the US.

“A young scientist joining a company like Syngene can travel the world scientifically without ever having to leave Bengaluru. It provides o...

NITI Aayog CEO Amitabh Kant, Pfizer CEO Dr Alberta Bourla, National Institutes of Health (NIH) Director Dr Francis Collins and Food and Dru...

Ahead of the 14th edition of the annual BioPharma and Healthcare Summit, that bring stakeholders from India and the United States on one pl...

The Indian market is expected to open higher. Here is a list of top twelve stocks that are likely to be in focus today.

Dr Reddy’s was among the first to race off the blocks with four launches in India about as many years. But things have slowed since.

Technology becomes more and more important as consumer technology companies grow. Facebook and Twitter now use analytics intensely.

Cipla, the Indian drugmaker that built a $1-billion business making generic HIV treatments, aims to sell copies of Roche Holding's and Amge...

Parag Saxena, one of the leading venture capitalists in the US and an early investor in Starbucks, is raising $1.5 billion for a dedicated ...

Dr. Reddy's Laboratories developing eight generic medicines using biotechnology.

A new chapter is being added to the Indian pharma story. Leading global pharma and biotechnology firms, such as Schering-Plough, Bristol-My...